The Journal of Allergy and Clinical Immunology
Volume 116, Issue 2 , Pages 305-311, August 2005

Dissecting asthma using focused transgenic modeling and functional genomics

  • Douglas A. Kuperman, PhD

      Affiliations

    • From the Department of Medicine, Allergy-Immunology Division, Northwestern University Feinberg School of Medicine, Chicago
    • Department of Medicine
    • Lung Biology Center
  • ,
  • Christina C. Lewis, PhD

      Affiliations

    • Department of Medicine
    • Lung Biology Center
  • ,
  • Prescott G. Woodruff, MD

      Affiliations

    • Department of Medicine
    • Division of Pulmonary and Critical Care Medicine
    • Cardiovascular Research Institute
  • ,
  • Madeleine W. Rodriguez, BS

      Affiliations

    • Department of Medicine
    • Lung Biology Center
  • ,
  • Yee Hwa Yang, PhD

      Affiliations

    • Department of Medicine
    • Lung Biology Center
  • ,
  • Gregory M. Dolganov, PhD

      Affiliations

    • Department of Medicine
    • Division of Pulmonary and Critical Care Medicine
    • Cardiovascular Research Institute
  • ,
  • John V. Fahy, MD

      Affiliations

    • Department of Medicine
    • Division of Pulmonary and Critical Care Medicine
    • Cardiovascular Research Institute
  • ,
  • David J. Erle, MD

      Affiliations

    • Department of Medicine
    • Lung Biology Center
    • Division of Pulmonary and Critical Care Medicine
    • Cardiovascular Research Institute
    • Program in Immunology, University of California San Francisco School of Medicine
    • Corresponding Author InformationReprint requests: David J. Erle, MD, UCSF Box 2922, San Francisco, CA 94143-2922.

Received 6 January 2005; received in revised form 28 February 2005; accepted 9 March 2005. published online 03 May 2005.

Chicago, Ill, and San Francisco, Calif

Background

Asthma functional genomics studies are challenging because it is difficult to relate gene expression changes to specific disease mechanisms or pathophysiologic features. Use of simplified model systems might help to address this problem. One such model is the IL-13/Epi (IL-13–overexpressing transgenic mice with STAT6 expression limited to epithelial cells) focused transgenic mouse, which isolates the effects of a single mediator, IL-13, on a single cell type, the airway epithelial cell. These mice develop airway hyperreactivity and mucus overproduction but not airway inflammation.

Objective

To identify how effects of IL-13 on airway epithelial cells contribute to gene expression changes in murine asthma models and determine whether similar changes are seen in people with asthma.

Methods

We analyzed gene expression in ovalbumin allergic mice, IL-13–overexpressing mice, and IL-13/Epi mice with microarrays. We analyzed the expression of human orthologues of genes identified in the mouse studies in airway epithelial cells from subjects with asthma and control subjects.

Results

In comparison with the other 2 models, IL-13/Epi mice had a remarkably small subset of gene expression changes. Human orthologues of some genes identified as increased in the mouse models were more highly expressed in airway epithelial cells from subjects with asthma than in controls. These included calcium-activated chloride channel 1, 15-lipoxygenase, trefoil factor 2, and intelectin.

Conclusion

The combination of focused transgenic models, DNA microarray analyses, and translational studies provides a powerful approach for analyzing the contributions of specific mediators and cell types and for focusing attention on a limited number of genes associated with specific pathophysiologic aspects of asthma.

Key words: Asthma, IL-13, calcium-activated chloride channel, trefoil factor, 15-lipoxygenase, intelectin

Abbreviations used: GAPD, Glyceraldehyde-3-phosphate dehydrogenase, IL-13/Epi, IL-13–overexpressing transgenic mice with STAT6 expression limited to epithelial cells, tg–IL-13, IL-13–overexpressing transgenic mice, STAT6, Signal transducer and activator of transcription factor 6, UCSF, University of California San Francisco

 

 Supported by National Institute of Health grants HL56835 and HL72301 and by the UCSF Sandler Center for Basic Research in Asthma.Disclosure of potential conflict of interest: D. A. Kuperman, none disclosed. C. A. Lewis, none disclosed. P. G. Woodruff, none disclosed. M. W. Rodriguez, none disclosed. Y. H. Yang, none disclosed. G. M. Dolganov, none disclosed. J. V. Fahy, none disclosed. D. J. Erle, none disclosed.

PII: S0091-6749(05)00598-1

doi:10.1016/j.jaci.2005.03.024

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 2 , Pages 305-311, August 2005